Integrating diagnostics and therapeutics: revolutionizing drug discovery and patient care.
Journal Article (Review)
Over the next five years it is widely anticipated that the molecular diagnostics industry will continue to grow at double-digit pace to meet increasing demand for personalized medicine. A wide variety of drugs in late preclinical and early clinical development is now being targeted to disease-specific gene and protein defects that will require co-approval of diagnostic and therapeutic products by regulatory agencies. For clinical laboratories and pathologists, this integration of diagnostics and therapeutics represents a major new opportunity to emerge as leaders of the new medicine, guiding the selection, dosage, route of administration and multi-drug combinations, and producing increased efficacy and reduced toxicity of pharmaceutical products.
Full Text
Duke Authors
Cited Authors
- Ross, JS; Ginsburg, GS
Published Date
- August 15, 2002
Published In
Volume / Issue
- 7 / 16
Start / End Page
- 859 - 864
PubMed ID
- 12546952
Pubmed Central ID
- 12546952
International Standard Serial Number (ISSN)
- 1359-6446
Digital Object Identifier (DOI)
- 10.1016/s1359-6446(02)02405-4
Language
- eng
Conference Location
- England